Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study.
Aerts JG, Belderbos R, Baas P, Scherpereel A, Bezemer K, Enninga I, Meijer R, Willemsen M, Berardi R, Fennell D, Kerstens R, Cornelissen R, van Meerbeeck JP; DENIM team. Aerts JG, et al. Among authors: willemsen m. Lancet Oncol. 2024 Jul;25(7):865-878. doi: 10.1016/S1470-2045(24)00191-8. Epub 2024 Jun 4. Lancet Oncol. 2024. PMID: 38848742 Clinical Trial.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
Dietz MV, Quintelier KLA, van Kooten JP, de Boer NL, Vink M, Brandt-Kerkhof ARM, Verhoef C, Saeys Y, Aerts JGJV, Willemsen M, Van Gassen S, Madsen EVE. Dietz MV, et al. Among authors: willemsen m. J Immunother Cancer. 2023 Aug;11(8):e007070. doi: 10.1136/jitc-2023-007070. J Immunother Cancer. 2023. PMID: 37536940 Free PMC article. Clinical Trial.
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction.
van Eijck CWF, Strijk G, Vietsch EE, van der Sijde F, Verheij M, Mustafa DAM, Vink M, Aerts JGJV, van Eijck CHJ, Willemsen M. van Eijck CWF, et al. Among authors: willemsen m. Eur J Cancer. 2024 Jan;196:113440. doi: 10.1016/j.ejca.2023.113440. Epub 2023 Nov 17. Eur J Cancer. 2024. PMID: 37988843 Free article.
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer.
van 't Land FR, Willemsen M, Bezemer K, van der Burg SH, van den Bosch TPP, Doukas M, Fellah A, Kolijn PM, Langerak AW, Moskie M, van der Oost E, Rozendaal NEM, Baart SJ, Aerts JGJV, van Eijck CHJ. van 't Land FR, et al. Among authors: willemsen m. J Clin Oncol. 2024 Sep 10;42(26):3083-3093. doi: 10.1200/JCO.23.02585. Epub 2024 Jul 1. J Clin Oncol. 2024. PMID: 38950309 Free PMC article. Clinical Trial.
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients.
Vietsch EE, Latifi D, Verheij M, van der Oost EWA, de Wilde RF, Haen R, van den Boom AL, Koerkamp BG, Doornebosch PG, van Verschuer VMT, Ooms AHAG, Mohammad F, Willemsen M, Aerts JGJV, Krog RT, de Miranda NFCC, van den Bosch TPP, Mueller YM, Katsikis PD, van Eijck CHJ. Vietsch EE, et al. Among authors: willemsen m. Front Immunol. 2023 Nov 10;14:1230306. doi: 10.3389/fimmu.2023.1230306. eCollection 2023. Front Immunol. 2023. PMID: 38022530 Free PMC article.
Exploring the Value of an Assessment for the Professional Coaching of Residents.
Teheux L, Coolen EHAJ, van Voorthuizen B, van den Udenhout FLH, Theeuwes BAM, Draaisma JMT, Willemsen MAAP, Bolte AC, Kuijer-Siebelink W, van der Velden JAEM. Teheux L, et al. Among authors: willemsen maap. J Grad Med Educ. 2024 Aug;16(4):436-444. doi: 10.4300/JGME-D-23-00876.1. Epub 2024 Aug 15. J Grad Med Educ. 2024. PMID: 39148888 Free PMC article.
651 results